All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practiceJuan Berenguer, Juan González‐García, Marisa Montes et al.|Hepatology|2018Cited by 79
COVID-19 in people living with HIV: A multicenter case-series studyAlfonso Cabello, Miguel Górgolas, R. Fernández‐Roblas et al.|International Journal of Infectious Diseases|2020Cited by 57
Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infectionNorma Rallón, José M. Benito, Alfonso Cabello et al.|PLoS ONE|2018Cited by 44
HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1Juan Berenguer, Juan González‐García, Antonio Olveira et al.|Open Forum Infectious Diseases|2019Cited by 4